A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase DeficiencyBarbara K. Burton, Anthony Quinn, Patrick Deegan et al.|New England Journal of Medicine|2015Cited by 244
Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1Pramod K. Mistry, Michel Peterschmitt, Elena Lukina et al.|JAMA|2015Cited by 156
Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with <scp>G</scp>aucher disease type 1: The phase 3 ENGAGE trialPramod K. Mistry, Michel Peterschmitt, Elena Lukina et al.|American Journal of Hematology|2017Cited by 99
A LC–MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogenJinglan Zhang, Chunli Yu, Makiko Yasuda et al.|Journal of Chromatography B|2011Cited by 50